@article{1fa2a68c96bc43ba9ef911ae4ed3621d,
title = "Re: Placebo responses in device studies",
author = "Goadsby, {Peter J.} and Dodick, {David W.} and Lipton, {Richard B.}",
note = "Funding Information: Dr Lipton He receives research support from the NIH: 2PO1 AG003949 (Program Director), 5U10 NS077308 (PI), 1RO1 AG042595 (Investigator), RO1 NS082432 (Investigator), K23 NS09610 (Mentor), K23AG049466 (Mentor). He also receives support from the Migraine Research Foundation and the National Headache Foundation. He serves on the editorial board of Neurology and as senior advisor to Headache. He has reviewed for the NIA and NINDS, holds stock options in eNeura Therapeutics and Biohaven Holdings; serves as consultant, advisory board member, or has received honoraria from: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Colucid, Dr. Reddy{\textquoteright}s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKlein, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta. He receives royalties from Wolff{\textquoteright}s Headache, 8th Edition, Oxford Press University, 2009, Wiley and Informa.",
year = "2018",
month = apr,
day = "1",
doi = "10.1177/0333102417722498",
language = "English (US)",
volume = "38",
pages = "1007--1008",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "5",
}